Suchergebnisse - "Yi, Zongbi"

PubPharm (4)

1

Everolimus in hormone receptor-positive metastatic breast cancer : PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

2

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

3

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

4

Biomarkers of Everolimus Sensitivity in Hormone Receptor-Positive Breast Cancer

enthalten in: Journal of breast cancer | 2017

von Yi, Z. | Ma, F.

1
[1]